(Q48399869)

English

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.

scientific article published in August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

cystic fibrosis

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

11

object named as

Louanne Storey

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

12

object named as

Toni Ashton

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Conroy Wong

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Lata Jayaram

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Noel Karalus

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Tam Eaton

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Cecilia Tong

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Hans Hockey

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

David Milne

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Wendy Fergusson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Christine Tuffery

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

0 references

publication date

1 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

380

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

9842

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

660-667

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-of-life determinants in patients with clinically stable bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of the St. George's Respiratory Questionnaire in bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality in bronchiectasis: a long-term study assessing the factors influencing survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in bronchiectasis mortality in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

British Thoracic Society guideline for non-CF bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Exacerbations in cystic fibrosis: 4--Non-cystic fibrosis bronchiectasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of action and clinical application of macrolides as immunomodulatory medications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchiectasis: CT/clinical correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of low-dose erythromycin in bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

COPD exacerbations: definitions and classifications.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterisation of the onset and presenting clinical features of adult bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between respiratory symptoms and medical treatment in exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Airway inflammation in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Azithromycin therapy for neutrophilic airways disease: myth or magic?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Azithromycin for prevention of exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Azithromycin and the risk of cardiovascular death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulatory effects of macrolide antibiotics - part 2: advantages and disadvantages of long-term, low-dose macrolide therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960953-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)60953-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22901887%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48399869&oldid=2171265492"